期刊文献+

大肠肿瘤COX-2的表达与临床病理特征的关系 被引量:6

Correlation of COX-2 expression and clinicopathological features of colorectal cancer
下载PDF
导出
摘要 目的:观察COX-2在大肠肿瘤不同发展阶段的表达,研究COX-2的表达与大肠肿瘤各临床病理特征之间的关系.方法:使用免疫组化染色法分别研究了76例外科手术切除的原发性大肠癌石蜡标本(早期大肠癌32例,进展期大肠癌44例)、33例大肠腺瘤、18例正常大肠黏膜活检组织中COX-2蛋白的表达;采用K-M半参数法和Cox模型分析COX-2蛋白的表达与进展期大肠癌预后的关系.结果:依表达程度由(-)至(++)四级计算,COX-2的表达率在正常结肠黏膜中分别为83.3%,16.7%,0%,0%;在结肠腺瘤中分别为12.1%,42.4%,36.4%,9.1%;早期结肠癌中分别为6.3%,28.1%,46.9%,18.7%;在进展期结肠癌中分别为6.8%,20.5%,18.2%,54.5%.除腺瘤组与早期癌组中COX-2的表达率无差别外,其余两两之间COX-2的表达率均有显著性差异(P<0.01).生存分析显示,COX-2高表达组与低表达组之间的生存曲线有显著性差异(P<0.05).Cox模型中单因素分析显示COX-2表达的死亡风险比为2.665(P<0.05);多因素分析显示COX-2表达是与进展期大肠癌术后患者预后相关的独立危险因素.结论:COX-2的表达在由正常大肠黏膜至大肠腺瘤和早期癌至进展期大肠癌发展过程中呈上调趋势.COX-2的表达是一种影响进展期大肠癌术后患者预后的独立危险因素. AIM:To investigate the expression of COX-2 on different stages of colorectal cancer and the correlation between the expression of COX-2 and its clinicopathological features. METHODS:The expression of COX-2 was determined by immunohistochemical staining in seventy-six surgical specimens of colorectal cancer (late stage 44 and early stage 32), 33 adenomas and 18 normal colonic mucosal tissues were biopsied endocscopically. The correlation of COX-2 with the survival rate was evaluated with Kaplan-Meier survival curves and Cox proportional hazards regression. RESULTS:The degree of expression of COX-2 was categorized into 4 grades ranged from “-” to “+++”, the expression grades in series in normal colonic mucosal tissues was 83.3 %, 16.7 %,0 %,0 %, respectively; that in adenomas was 12.1 %, 42.4 %,36.4 %,9.1 %, respectively. The difference of the expression of COX-2 between late stage and early stage of colorectal cancer, and that between the late stage of cancer and adenoma were statistically significant (P <0.01); however, no significant difference in the expression of COX-2 between early stage of cancer and adenoma was observed. A significant difference in the survival curves between low COX-2 expression group and high COX-2 expression group was showed by Kaplan-Meier survival analysis (P <0.05). Cox proportional hazards regression indicated that the correlation of the expression of COX-2 with the poor long-term prognosis was existed with a hazard ratio of 2.665 unadjusted for other variables (P <0.05); the expression of COX-2 was an independent risk factor for poor prognosis. CONCLUSION:The expression of COX-2 is gradually up- regulated in the evolution of normal epithelium to adenomaor from early stage to advanced stage of colorectal cancer. The expression of COX-2 is an independent risk factor of poor prognosis for postoperative patients with advanced colorectal cancer.
出处 《世界华人消化杂志》 CAS 2003年第3期306-309,共4页 World Chinese Journal of Digestology
  • 相关文献

参考文献6

二级参考文献21

  • 1王强,范列英,何金,王元和.苏灵大对甲基亚硝基脲诱导的小鼠大肠肿瘤的抑制作用[J].新消化病学杂志,1997,5(7):425-426. 被引量:1
  • 2Choitsu Sakamoto. Roles of COX-1 and COX-2 in gastrointestinal pathophysiology[J] 1998,Journal of Gastroenterology(5):618~624 被引量:1
  • 3Raymond N. Dubois,Linda M. Hylind,C. Rahj Robinson,Walter C. Hubbard,Stanley R. Hamilton,Vincent W. Yang,Francis M. Giardiello,Ernst W. Spannhake. Prostaglandin Levels in Human Colorectal Mucosa (Effects of Sulindac in Patients with Familial Adenomatous Polyposis)[J] 1998,Digestive Diseases and Sciences(2):311~316 被引量:1
  • 4Ratnasinghe D,Tangrea JA,Roth MJ,Dawsey SM,Anver M,Kasprzak BA,Hu N,Wean QH,Taylor PR.Expression of cyclooxygenase-2 in human adenocarcinomas of the gastric cardia and corpus[].Oncology Reports.1999 被引量:1
  • 5Hao X,Bishop AE,Wallace M,Wang H,Willcocks TC,Maclouf J,Polak JM,Knight S,Talbot IC.Early expression of cyclooxygenase-2 during sporadic colorectal carcinogenesis[].Journal of Paleopathology.1999 被引量:1
  • 6Murata H,Kawano S,Tsuji S,et al.Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma[].American Journal of Gastroenterology.1999 被引量:1
  • 7Yamamoto H,,Itoh F,,Fukushima H,,Hinoda Y,,Imai K.Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability[].International Journal of Cancer.1999 被引量:1
  • 8Ratnasinghe D,Tangrea J,Roth MJ,etal.Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus;An immunohistochemical survey[].Anticancer Research.1999 被引量:1
  • 9王仰坤,纪小龙,马乃绪.胃粘膜异型增生形态与p53,Bcl-2和c-erbB-2表达的关系[J].世界华人消化杂志,1999,7(2):114-116. 被引量:26
  • 10涂水平,江石湖,谭继宏,蒋晓华,乔敏敏,章永平,吴云林,吴裕忻.氧化砷抑制胃癌SGC-7901细胞增殖和诱导凋亡作用[J].世界华人消化杂志,1999,7(1):18-21. 被引量:67

共引文献172

同被引文献75

  • 1Yun-Lin Wu~1 Bo Sun~1 Xue-Jun Zhang~2 Sheng-Nian Wang~2 Heng-Yi He~2 Min-Min Qiao~1 Jie Zhong~1 Jia-Yu Xu~1 1 Department of Gastroenterology,Ruijin Hospital,Shanghai Second Medical University,Shanghai 200025,China2 Institude of Biochemistry and Cell Biology,Shanghai Institues for Biological Sciences,Chinese Academy of Sciences.Shanghai 200025,China.Growth inhibition and apoptosis induction Sulindac on Human gastric cancer cells[J].World Journal of Gastroenterology,2001,7(6):796-800. 被引量:64
  • 2Shan-RunLiu BoZhao Zhen-JunWang Yuan-LianWan Yan-TingHuang.Clinical features and mismatch repair gene mutation screening in Chinese patients with hereditary nonpolyposis colorectal carcinoma[J].World Journal of Gastroenterology,2004,10(18):2647-2651. 被引量:19
  • 3郑松柏,项平,徐富星,欧平安.大肠黑变病的流行病学、临床及内镜特征[J].中华消化内镜杂志,2005,22(2):115-117. 被引量:51
  • 4黄跃南,郭欣,王夫景.结肠黑变病的研究现状及进展[J].世界华人消化杂志,2005,13(24):2862-2865. 被引量:19
  • 5Takemasa I, Yamamoto H, Sekimoto M, Ohue M, Noura S,Miyake Y, Matsumoto T, Aihara T, Tomita N, Tamaki Y,Sakita I, Kikkawa N, Matsuura N, Shiozaki H, Monden M.Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma. Cancer Res 2000:60:3043-3050. 被引量:1
  • 6Hemandez S, Bessa X, Bea S, Hemandez L, Nadal A, Mallofre C, Muntane J,Castells A, Fernandez PL, Cardesa A, Campo E. Differential expression of cdc25 cell-cycle-activating phosphatases in human colorectal carcinoma. Lab Invest 2001;81:465-473. 被引量:1
  • 7Lazo JS, Nemoto K, Pestell KE, Cooley K, Southwick EC,Mitchell DA, Furey W,Gussio R, Zaharevitz DW, Joo B, Wipf P. Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors. Mol Pharmacol 2002;61:720-728. 被引量:1
  • 8Lazo JS, Aslan DC, Southwick EC, Cooley KA, Ducruet AP,Joo B, Vogt A, Wipf P, Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25. J Med Chem 2001;44:4042-4049. 被引量:1
  • 9Sodeoka M, Sampe R, Kojima S, Baba Y, Usui T, Ueda K,Osada H. Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual- specificity protein phosphatases and its evaluation regarding VHR andcdc25B inhibition. J Med Chem 2001;44:3216-3222. 被引量:1
  • 10Kanbagli O, Balkan J', Aykac-Toker G, Uysal M. Hepatic mitochondrial prooxidant and antioxidant status in ethanol-induced liver injury in rats. Biol Pharm Bull 2002;25:1482-1484. 被引量:1

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部